Statistics

Total Visits

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel31

Select a period of time:

Number of views in the range

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel18

Views

Views
January 20250
February 20251
March 202514
April 20252
May 20251
June 20250
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States2
Spain1
United Kingdom1
 

Top cities views

Views
Council Bluffs1
Harringay1